Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

155.76
-1.5445-0.98%
Volume:556.15K
Turnover:86.80M
Market Cap:374.76B
PE:17.34
High:156.65
Open:155.82
Low:155.35
Close:157.30
Loading ...

BRIEF-Johnson & Johnson CFO Joe Wolk On Tariffs On Imported Pharmaceuticals Says I Don't Want To Speculate, I Want The Process To Play Out - CNBC Interview

Reuters
·
15 Apr

Johnson & Johnson CFO Joe Wolk on Tariffs on Imported Pharmaceuticals: I Don't Want to Speculate, I Want the Process to Play Out - CNBC Interview

THOMSON REUTERS
·
15 Apr

Stocks that benefit from chaos are helping a husband-and-wife investing duo beat the competition

Dow Jones
·
15 Apr

Johnson & Johnson Shares Rise On Q1 Profit And Revenue Beat And Raised Guidance -- MarketWatch

Dow Jones
·
15 Apr

Johnson & Johnson anticipates 2025 milestones driving long-term value creation

TIPRANKS
·
15 Apr

Johnson & Johnson's Q1 Adjusted Earnings, Revenue Rise; Reiterates 2025 Adjusted Earnings Guidance

MT Newswires Live
·
15 Apr

Johnson & Johnson Announces 63Rd Consecutive Year Of Dividend Increase; Raises Quarterly Dividend By 4.8%

Reuters
·
15 Apr

Johnson & Johnson Raises Dividend by 4.8%, Extending Royal Payout Run

Dow Jones
·
15 Apr

Johnson & Johnson Raises Quarterly Dividend by 4.8% to $1.30 a Share, Payable June 10 to Shareholders as of May 27

MT Newswires Live
·
15 Apr

Johnson & Johnson: Q1 Earnings Snapshot

Associated Press Finance
·
15 Apr

BRIEF-Johnson & Johnson Q1 adjusted EPS USD 2.77 vs. IBES estimate USD 2.59

Reuters
·
15 Apr

Johnson & Johnson Q1 2025 Adj EPS $2.77 Beats $2.60 Estimate, Sales $21.89B Beat $21.58B Estimate

Benzinga
·
15 Apr

Johnson & Johnson Announces 63Rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%

THOMSON REUTERS
·
15 Apr

Johnson & Johnson Announces 63rd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.8%

Business Wire
·
15 Apr

Johnson & Johnson Expects 2025 Adjusted EPS Of $10.50-$10.70 Versus Prior Guidance Of $10.75–$10.95 And Consensus Of $10.46

Benzinga
·
15 Apr

Johnson & Johnson Expects 2025 Sales Of $91B-$91.8B Versus Prior Guidance Of $90.9B–$91.7B And Consensus Of $90.62B

Benzinga
·
15 Apr

J&J Q1 Adj EPS $2.77 VS Ibes Estimate $2.59

THOMSON REUTERS
·
15 Apr

J&J Outlook FY Oper Sales $91.6 Bln - $92.4 Bln VS Ibes Estimate $90.65 Bln

THOMSON REUTERS
·
15 Apr

Johnson & Johnson Q1 Adjusted EPS USD 2.77 VS. Ibes Estimate USD 2.59

THOMSON REUTERS
·
15 Apr

Johnson & Johnson Reports Q1 2025 Results

THOMSON REUTERS
·
15 Apr